News & Updates
Showing Pharmacy articles
Showing
Fluvoxamine improves fatigue, QoL in long COVID patients
Patients with long COVID may derive benefits from treatment with fluvoxamine, which has been shown to reduce fatigue and improve quality of life (QoL) in a study. The use of metformin, on the other hand, shows no significant advantage.
Fluvoxamine improves fatigue, QoL in long COVID patients
19 Apr 2026
Cannabis may reduce risk of some skin cancers
The use of cannabis appears to result in a lower incidence of basal cell carcinoma (BCC) over 10 years, but not cutaneous squamous cell carcinoma (cSCC) or malignant melanoma (MM), suggests a recent study presented at AAD 2026.
Cannabis may reduce risk of some skin cancers
18 Apr 2026
Methotrexate may lower CV risk in psoriasis patients
Patients with psoriasis who are treated with methotrexate (MTX) show a reduced incidence of metabolic syndrome and better cardiometabolic profiles, according to a study presented at AAD 2026.
Methotrexate may lower CV risk in psoriasis patients
17 Apr 2026
Post-exposure PIP comparable to PrEP for low-risk HIV, but more affordable
Post-exposure prophylaxis-in-pocket (PIP) appears as effective as pre-exposure prophylaxis (PrEP) in improving quality of life (QoL) of individuals at low risk for HIV but may be a less costly option, according to a matched-control study presented at CROI 2026.
